Whitehall, PA, United States of America

Richard Cordova

This inventor holds 3 USPTO granted patents. Top assignees: Johnson & Johnson Consumer Companies, Inc., Ortho Pharmaceutical Corporation, Ortho-Mcneil Pharmaceutical Corp.. Active years: 2002-2006.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 61(Granted Patents)


Company Filing History:


Years Active: 2002-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Richard Cordova: Innovator in Anti-Inflammatory Compounds

Introduction

Richard Cordova is a notable inventor based in Whitehall, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory compounds. With a total of 3 patents to his name, Cordova's work has had a meaningful impact on medical science.

Latest Patents

One of Richard Cordova's latest patents focuses on anti-inflammatory compounds. This invention relates to the creation of compounds, methods of making such compounds, and methods of using these compounds, which possess a specific structure. His innovative approach aims to provide effective solutions for inflammation-related conditions.

Career Highlights

Throughout his career, Richard Cordova has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Ortho-McNeil Pharmaceutical Corporation and Johnson & Johnson Consumer Companies, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in healthcare.

Collaborations

Richard Cordova has collaborated with esteemed colleagues, including Malcolm K. Scott and Pauline J. Sanfilippo. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Richard Cordova is a distinguished inventor whose work in anti-inflammatory compounds has made a lasting impact on the pharmaceutical industry. His contributions continue to influence the development of effective treatments for inflammation-related conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…